COMMUNIQUÉS West-GlobeNewswire

Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results
15/02/2018
Company Provides 2018 Financial Guidance and Expected Milestones; Reduced Operating Expenses vs. 2017; Over Two Years of Cash Based on Current Burn Rate CK-2127107 Advancing in Four Clinical Trials Under Collaboration [...]
Burgess Source Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance
15/02/2018
ALEXANDRIA, Va., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Burgess, an innovator in healthcare payment operations for over 20 years, today announced that Burgess Group's Source Application has earned Certified status for [...]
Inovalon to Participate at 2018 RBC Capital Markets Global Healthcare Conference
15/02/2018
BOWIE, Md., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
LHC Group Announces Fourth Quarter and Year-End 2017 Earnings Release and Conference Call Dates
15/02/2018
LAFAYETTE, La., Feb. 15, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG ) today announced details for the release of its results for the fourth quarter and year ended December 31, 2017. LHC Group plans to issue [...]
FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation
15/02/2018
– PDUFA date set for August 21, 2018 – CAMBRIDGE, Mass., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic [...]
Diaxonhit : Distribution exclusive de la plateforme de biologie moléculaire VERIGENE®
15/02/2018
Distribution exclusive de la plateforme de biologie moléculaire VERIGENE® Diaxonhit devient, par l'intermédiaire de sa filiale eurobio-ingen, le distributeur exclusif de la gamme de biologie moléculaire VERIGENE® de la [...]
GUERBET : 2017 revenue at constant exchange rates: €812.4 million; +4.7%
15/02/2018
Villepinte, February 15, 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €807.1 million at December 31, 2017, up by 4.0% at current [...]
GUERBET : Chiffre d'affaires 2017 à taux de change constant : 812,4 M€ ; +4,7%
15/02/2018
Villepinte, le 15 février 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie un chiffre d'affaires de 807,1 M€ au 31 décembre 2017, en [...]
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
15/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
PetVivo Holdings, Inc. Adds Special Revenue Consultant Approaching Commercial Production
15/02/2018
MINNEAPOLIS, Feb. 15, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKET:PETV) an emerging biomedical device Company, is moving Mr. David Merrill, a member of the Board of Directors, to cover [...]
JAMA Oncology Publication Demonstrates EndoPredict® (EPClin) Significantly Outperforms Oncotype DX® Recurrence Score in Early-Stage Breast Cancer
15/02/2018
SALT LAKE CITY, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ) today announced that a comparative analysis of commercially available prognostic breast cancer tests in patients with early-stage [...]
Daré Bioscience, Inc. Announces Effective License and Collaboration Agreement for Topical Sildenafil for Female Sexual Arousal Disorder
15/02/2018
SAN DIEGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that it has met the funding requirement for obtaining an exclusive [...]
Sales of Olainfarm in January Exceed 9 Million Euros
15/02/2018
Olaine, 2018-02-15 17:03 CET (GLOBE NEWSWIRE) -- January 2018, consolidated sales Sales, Thsnd. EUR Changes to January 2017 Share in total sales Latvia 2 922 18% 32% Russia 1 716 -27% 19% Belarus 1 696 5% 18% Ukraine 1 [...]
Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer
15/02/2018
– Confirmed partial responses observed in five of six evaluable patients with HRAS mutant HNSCC – – Rate of enrollment increasing with three additional patients enrolled in four months – – Initiation of registrational [...]
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
15/02/2018
BATON ROUGE, La., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), announced today that it will report results for the fourth quarter and year ended December 31, 2017 after the market closes on February [...]
Sienna Announces February Dividend
15/02/2018
MARKHAM, Ontario, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced a dividend of $0.075 per common share of the Company (each, a “Common Share”) for [...]
Solon Eiendom ASA : Notice of extraordinary general meeting
15/02/2018
(Oslo, 15 February 2018) Solon Eiendom ASA (OSE: SOLON), calls for the extraordinary general meeting to be held at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 09 March 2018 at 10 am (CET). The notice [...]
Immunovaccine Announces Closing of $14.375 million Bought Deal Offering with Over-allotment option exercised in full
15/02/2018
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, N.S., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (“Immunovaccine” or the “Corporation”) (TSX: IMV ) (OTCQX:IMMVF), a [...]
Immunovaccine annonce la clôture d’un placement par voie de prise ferme de 14,375 millions de dollars compte tenu de l’option de surallocation intégralement exercée
15/02/2018
NE PAS DISTRIBUER À DES AGENCES DE TRANSMISSION DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNIS HALIFAX, N.S., 15 févr. 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (« Immunovaccine » ou la « société ») (TSX: IMV ) (OTCQX: [...]

Pages